首页> 外文OA文献 >One-fits-all pretreatment protocol facilitating Fluorescence In Situ Hybridization on formalin-fixed paraffin-embedded, fresh frozen and cytological slides
【2h】

One-fits-all pretreatment protocol facilitating Fluorescence In Situ Hybridization on formalin-fixed paraffin-embedded, fresh frozen and cytological slides

机译:促进福尔林固定石蜡包埋,新鲜冷冻和细胞学载玻片原位杂交的一定的预处理方案

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Abstract Background The Fluorescence In Situ Hybridization (FISH) technique is a very useful tool for diagnostic and prognostic purposes in molecular pathology. However, clinical testing on patient tissue is challenging due to variables of tissue processing that can influence the quality of the results. This emphasizes the necessity of a standardized FISH protocol with a high hybridization efficiency. We present a pretreatment protocol that is easy, reproducible, cost-effective, and facilitates FISH on all types of patient material simultaneously with good quality results. During validation, FISH analysis was performed simultaneously on formalin-fixed paraffin-embedded, fresh frozen and cytological patient material in combination with commercial probes using our optimized one-fits-all pretreatment protocol. An optimally processed sample is characterized by strong specific signals, intact nuclear membranes, non-disturbing autofluorescence and a homogeneous DAPI staining. Results In our retrospective cohort of 3881 patient samples, overall 93% of the FISH samples displayed good quality results leading to a patient diagnosis. All FISH were assessed on quality aspects such as adequacy and consistency of signal strength (brightness), lack of background and / or cross-hybridization signals, and additionally the presence of appropriate control signals were evaluated to assure probe accuracy. In our analysis 38 different FISH probes from 3 commercial manufacturers were used (Cytocell, Vysis and ZytoLight). The majority of the patients in this cohort displayed good signal quality and barely non-specific background fluorescence on all tissue types independent of which commercial probe was used. Conclusion The optimized one-fits-all FISH method is robust, reliable and reproducible to deliver an accurate result for patient diagnostics in a lean workflow and cost-effective manner. This protocol can be used for widespread application in cancer and non-cancer diagnostics and research.
机译:摘要背景原位杂交(鱼类)技术的荧光是分子病理学诊断和预后目的的非常有用的工具。然而,由于可以影响结果质量的组织处理的变量,患者组织的临床检测是挑战性的。这强调了具有高杂交效率的标准化鱼协议的必要性。我们提出了一种预处理方案,可轻松,可重复,经济效益,并促进各种类型的患者材料,同时具有良好的质量结果。在验证期间,使用我们优化的单件预处理方案,在福尔马林固定的石蜡包埋,新鲜冷冻和细胞学患者材料上同时进行鱼类分析。最佳加工的样品的特征在于强大的特定信号,完整的核膜,无扰动的自发荧光和均匀的DAPI染色。结果我们的回顾性队列3881例患者样品,总共93%的鱼类样品显示出良好的质量结果,导致患者诊断。所有鱼类都在质量方面进行评估,例如信号强度的充分性和一致性(亮度),缺乏背景和/或交叉杂交信号,并且另外评估适当的控制信号以确保探针精度。在我们的分析中,使用了38种不同的鱼探针(Cytocell,群体和Zytolight)。在这种队列中的大多数患者显示出良好的信号质量,并且在所有组织类型上显示出良好的非特异性背景荧光,无论是否使用哪种组织类型。结论优化的单位鱼类方法是坚固,可靠的,可重复的,以便以精益的工作流程为患者诊断提供准确的结果,以瘦弱的工作流程和成本效益。该方案可用于癌症和非癌症诊断和研究中的广泛应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号